Todays approval in the frontline consolidation phase, regardless of MRD status, allows us to reach more patients than ever with this transformative, first-in-class Bispecific T-cell Engager (BiTE) therapy, Jay Bradner, executive vice president of research and development and chief scientific officer at Amgen, said in a press release
Regardless of company or plan size, the costs associated with these life-changing anti-obesity medications are astounding and often unmanaged
Welcome to the For the Love Podcast , with your host Jen Hatmaker, my mom
People might feel nausea, vomiting, or diarrhea
If nausea occurs primarily in the morning, eating a light carbohydrate-based snack (such as crackers or toast) before getting out of bed can prevent an empty stomach from amplifying the sensation